Antihormonal to Leukemia--Modified Cytokine Receptor

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 CA63861-1,
Agency Tracking Number: 24863
Amount: $692,768.00
Phase: Phase II
Program: SBIR
Awards Year: 1995
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
4853 Cordell Avenue #1407, Bethesda, MD, 20814
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 David Hankins
 (301) 652-2130
Business Contact
Phone: () -
Research Institution
This Phase I is designed to test feasibility of developing immunotoxins for human lymphoidleukemia using IL-2 and either 90Y or 131I. There is ample evidence that many cases of humanleukemia are cytokine-dependent. The Principal Investigator has long experience in the study oferythropoietin-dependent erythroleukemia induced by Friend's spleen focus forming virus. Recently,several clinical trials have already established the efficacy of immunotoxin approach in certainmalignancies and other diverse conditions such as autoimmune disorders and graft vs. host diseases.In this application, we will test bioactivity of human recombinant prepare and purify 131I-IL-2, prepareand purify 90Y-IL-2, analyze the radiolabeled IL-2 compounds and test specificity of the compoundsusing cell lines that are dependent on other cytokines. We will also test the effects on primary murineand human T-cells.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government